Table 4.
Study Group | Basal | 3h Post RE | 6h Post RE |
---|---|---|---|
LAT1/SLC7A5 mRNA, Fold Change | |||
RE+EAA | 1.09 ± 0.19 | 3.92 ± 1.43* | 5.88 ± 2.25* |
RE | 1.33 ± 0.31 | 4.08 ± 0.82* | 4.06 ± 1.40* |
SNAT2/SLC38A2 mRNA, Fold Change | |||
RE+EAA | 1.02 ± 0.08 | 1.74 ± 0.52‡ | 1.21 ± 0.37 |
RE | 1.01 ± 0.16 | 1.63 ± 0.35‡ | 1.08 ± 0.40 |
PAT1/SLC36A1 mRNA, Fold Change | |||
RE+EAA | 1.02 ± 0.10 | 1.33 ± 0.32 | 1.73 ± 0.37 |
RE | 1.29 ± 0.38 | 1.63 ± 0.14 | 2.71 ± 0.64* |
CAT1/SLC7A1 mRNA, Fold Change | |||
RE+EAA | 1.05 ± 0.14 | 3.53 ± 0.93‡ | 5.02 ± 1.20‡ |
RE | 1.27 ± 0.18 | 3.79 ± 1.15‡ | 5.37 ± 1.70‡ |
CD98/SLC3A2 mRNA, Fold Change | |||
RE+EAA | 1.01 ± 0.05 | 1.18 ± 0.28 | 1.48 ± 0.25 |
RE | 1.35 ± 0.27 | 1.50 ± 0.21 | 2.04 ± 0.33* |
LAT1 Protein, Fold Change | |||
RE+EAA | 1.00 | 1.27 ± 0.20 | 1.24 ± 0.21 |
RE | 1.00 | 1.10 ± 0.14 | 0.90 ± 0.13 |
SNAT2 Protein, Fold Change | |||
RE+EAA | 1.00 | 1.20 ± 0.11 | 0.82 ± 0.19 |
RE | 1.00 | 1.00 ± 0.01 | 0.99 ± 0.01 |
Data are mean±SE. RE+EAA = resistance exercise followed by ingestion of 20 g of essential amino acids 1h following exercise; RE = resistance exercise without EAA ingestion. RE+EAA, n = 6; RE, n = 8 (mRNA) and n = 7 (SNAT2 protein) and n = 6 (LAT1 protein).
Significant change from basal (p<0.05);
Significant time effect vs. basal (p<0.05).